Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

November 2010 - FRMC

Department

Conference Insider
11/19/2010

Tori Socha

Tori Socha
There is variability in the comprehensiveness and reliability of national compendia for options for treatment of conditions such as cancer.
There is variability in the comprehensiveness and reliability of national compendia for options for treatment of conditions such as cancer.
There is variability in the...
11/19/2010
First Report Managed Care
Conference Insider
11/19/2010

Tim Casey

Tim Casey
The Patient Protection and Affordable Care Act introduces guidelines regarding quality improvement and makes quality a major part of the national healthcare strategy.
The Patient Protection and Affordable Care Act introduces guidelines regarding quality improvement and makes quality a major part of the national healthcare strategy.
The Patient Protection and...
11/19/2010
First Report Managed Care
Conference Insider
11/19/2010

Tori Socha

Tori Socha
The Patient Protection and Affordable Care Act includes several provisions that affect the Medicare Part D drug benefit. At a contemporary issues presentation at the AMCP meeting, attendees were given an overview of the 10-year program...
The Patient Protection and Affordable Care Act includes several provisions that affect the Medicare Part D drug benefit. At a contemporary issues presentation at the AMCP meeting, attendees were given an overview of the 10-year program...
The Patient Protection and...
11/19/2010
First Report Managed Care
Conference Insider
11/18/2010

Tim Casey

Tim Casey
St. Louis—At a satellite symposium at the AMCP meeting, a trio of speakers discussed the use of biologics in chronic diseases as well as the different pharmacy benefit designs, opportunities, challenges, trends, and costs associated with the...
St. Louis—At a satellite symposium at the AMCP meeting, a trio of speakers discussed the use of biologics in chronic diseases as well as the different pharmacy benefit designs, opportunities, challenges, trends, and costs associated with the...
St. Louis—At a satellite...
11/18/2010
First Report Managed Care
Feature
11/19/2010

Tim Casey

Tim Casey
St. Louis—In a presentation titled Mitigating Risks from Non–FDA-Approved Drugs, presenters explained that thousands of drugs not approved by the US Food and Drug Administration (FDA) are available, accounting for a total of 72 million...
St. Louis—In a presentation titled Mitigating Risks from Non–FDA-Approved Drugs, presenters explained that thousands of drugs not approved by the US Food and Drug Administration (FDA) are available, accounting for a total of 72 million...
St. Louis—In a presentation...
11/19/2010
First Report Managed Care
Feature
11/19/2010

Tim Casey

Tim Casey
St. Louis—Multiple sclerosis (MS), the most common chronic disease affecting the central nervous system in young adults, presents a series of health- and cost-related threats but can be treated with several therapies that were described at a...
St. Louis—Multiple sclerosis (MS), the most common chronic disease affecting the central nervous system in young adults, presents a series of health- and cost-related threats but can be treated with several therapies that were described at a...
St. Louis—Multiple sclerosis...
11/19/2010
First Report Managed Care
Feature
11/19/2010

Tim Casey

Tim Casey
St. Louis—As the costs associated with rheumatoid arthritis (RA) rise, health plans and providers must enhance RA management and understand the need for early and aggressive treatment of the disease, 4 speakers said during a satellite...
St. Louis—As the costs associated with rheumatoid arthritis (RA) rise, health plans and providers must enhance RA management and understand the need for early and aggressive treatment of the disease, 4 speakers said during a satellite...
St. Louis—As the costs...
11/19/2010
First Report Managed Care
Feature
11/19/2010

Tori Socha

Tori Socha
St. Louis—It is estimated that the population prevalence of chronic migraine (CM) in the United States is from 1.4% to 2.2%. CM is a complication of migraine and is defined as ≥15 headache days per month and at least 8 headache days per month...
St. Louis—It is estimated that the population prevalence of chronic migraine (CM) in the United States is from 1.4% to 2.2%. CM is a complication of migraine and is defined as ≥15 headache days per month and at least 8 headache days per month...
St. Louis—It is estimated that...
11/19/2010
First Report Managed Care
11/19/2010

Tori Socha

Tori Socha
Managing obesity and type 2 diabetes puts a strain on the healthcare system. According to researchers, treatments for obesity focusing on dietary, pharmaceutical, and behavior modifications are associated with high rates of failure, and...
Managing obesity and type 2 diabetes puts a strain on the healthcare system. According to researchers, treatments for obesity focusing on dietary, pharmaceutical, and behavior modifications are associated with high rates of failure, and...
Managing obesity and type 2...
11/19/2010
First Report Managed Care
Feature
11/18/2010

Tim Casey

Tim Casey
St. Louis—Health insurers, pharmacy benefit managers (PBMs), and other healthcare and pharmacy-related businesses must take seriously the impact and high costs associated with pharmacy fraud and crime, according to information presented...
St. Louis—Health insurers, pharmacy benefit managers (PBMs), and other healthcare and pharmacy-related businesses must take seriously the impact and high costs associated with pharmacy fraud and crime, according to information presented...
St. Louis—Health insurers,...
11/18/2010
First Report Managed Care

Advertisement

Advertisement

Advertisement